Lithium-induced subclinical hypothyroidism: Review of the literature and guidelines for treatment

Journal of Clinical Psychiatry

Volumn 60, Issue 4, 1999, Pages 249-255

  Kleiner, Jillian ^a   Altshuler, Lori ^a,b,c   Hendrick, Victoria ^a   Hershman, Jerome M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; THYROTROPIN; THYROXINE;

CLINICAL FEATURE; HUMAN; HYPOTHYROIDISM; MANIC DEPRESSIVE PSYCHOSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; THYROID DISEASE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL;

EID: 0032947855     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v60n0409     Document Type: Review

References (96)

1. Goodwin K, Jamison K. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990:453-455, 634-635, 672, 677, 702-704
2. Hullin RP. The place of lithium in biological psychiatry, In: Johnson FN, Johnson S, eds. Lithium in Medical Practice. Lancaster, England: MTP Press; 1978:433
3. Annick V, Baruch P, Vincent P. Early onset of lithium-associated hypothyroidism. J Psychiatr Neurosci 1993;18:74-77
4. Cho J, Bone S, Dunner D, et al. The effect of lithium treatment on patients with primary affective disorder. Am J Psychiatry 1971;36:115-116
5. Cowdry R, Wehr T, Zis A, et al. Thyroid abnormalities association with rapid cycling bipolar illness. Arch Gen Psychiatry 1983;40:412-420
6. Joffe R, Kutcheer S, MacDonald C. Thyroid function and bipolar affective disorder. Psychiatry Res 1987;21:117-121
7. Surks MI, Ocampo E. Subclinical thyroid disease. Am J Med 1996;100: 217-223
8. Haggerty JJ, Prange AJ. Borderline hypothyroidism and depression. Annu Rev Med 1995;46:37-46
9. Howland RH. Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment. J Clin Psychiatry 1993;54:47-54
10. Stein D, Avni J. Thyroid hormones in the treatment of affective disorders. Acta Psychiatr Scand 1988;77:623-636
11. Haggerty JJ, Garbutt JC, Evans DL, et al. Subclinical hypothyroidism: a review of neuro-psychiatric aspects. Intl J Psychiatry Med 1990;20: 193-208
12. Haggerty JJ, Stern RA, Mason GA, et al. Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry 1993;150:508-510
13. Hatterer JA, Kocsis JH, Stokes PE. Thyroid function in patients maintained on lithium. Psychiatry Res 1988;26:249-257
14. Gold MS, Pottash ALC, Extein I. Hypothyroidism and depression: evidence from complete thyroid function evaluation. JAMA 1981;245: 1919-1922
15. Haggerty JJ, Evans DL, Prange AJ Jr. Organic brain syndrome associated with marginal hypothyroidism. Am J Psychiatry 1986;143:785-786
16. Nystrom E, Caidahl K, Fager G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with "subclinical" hypothyroidism. Clin Endocrinol (Oxf) 1988;29:63-75
17. Joffe RT, Levitt AJ. Major depression and subclinical (grade 2) hypothyroidism. Psychoneuroendocrinology 1992;17:215-221
18. Targum SD, Greenberg RD, Harmon RL, et al. Thyroid hormone and the TRH stimulation test in refractory depression. J Clin Psychiatry 1984;45: 345-346
19. Wehr TW, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979;36:555-559
20. O'Shannick GJ, Ellinwood EH. Persistent elevation of thyroid-stimulating hormone in women with bipolar affective disorder. Am J Psychiatry 1982; 139:513-514
21. Extein I, Pottash AL, Gold MS. Does subclinical hypothyroidism predispose to tricyclic-induced rapid mood cycles? J Clin Psychiatry 1982;43: 290-291
22. Tollefson G, Valentine R, Hoffmann N, et al. Thyroxine binding and TSH in recurrent depressive episodes. J Clin Psychiatry 1985;46:267-272
23. Monzani F, Del Guerra P, Caraccio N, et al. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig 1993;71:367-371
24. Bauer M, Whybrow P. Rapid cycling bipolar affective disorder, I: association with grade I hypothyroidism. Arch Gen Psychiatry 1990;47:427-432
25. Bauer M, Whybrow P. Rapid cycling bipolar affective disorder, II: treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry 1990;47:435-440
26. 3, basal TSH, and TRH-test. Eur J Clin Invest 1974;4:141-148
27. Cooper DS, Halpern R, Wood LC, et al. L-Thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 1984;101:18-24
28. Hart IR. Management decisions in subclinical thyroid disease. Hosp Pract (Off Ed) 1995;30:43-50
29. Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med 1990;112:840-849
30. Wilansky DL, Greisman B. Early hypothyroidism in patients with menorrhagia. Am J Obstet Gynecol 1989;160:673-677
31. Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992;92:631-642
32. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977;7: 489-493
33. Tunbridge WM, Brewis M, French JM, et al. Natural history of autoimmune thyroiditis. BMJ 1981;282:258-262
34. Sawin CT, Castelli WP, Hershman JM, et al. The aging thyroid: thyroid deficiency in the Framingham Study. Arch Intern Med 1985;145: 1386-1388
35. Rosenthal MJ, Hunt WC, Garry PJ, et al. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA 987;258: 209-213
36. Lee S, Chow C, Wing Y, et al. Thyroid abnormalities during chronic lithium treatment in Hong Kong Chinese: a controlled study. J Affect Disord 1992;26:173-178
37. Cushing GW. Subclinical hypothyroidism: understanding is the key to decision making. Postgrad Med 1993;94:95-107
38. Kabadi UM. Subclinical hypothyroidism: natural course of the syndrome during prolonged follow-up study. Arch Intern Med 1993;153:957-961
39. Amdisen A, Andersen CJ. Lithium treatment and thyroid function: a survey of 237 patients in long-term lithium treatment. Pharmacopsychiatria 1982;15:149-155
40. Piziak VK, Sellman JE, Othmer E. Lithium and hypothyroidism. J Clin Psychiatry 1978;39:709-711
41. Smigan L, Wahlin A, Jacobsson L, et al. Lithium therapy and thyroid function tests: a prospective study. Neuropsychobiology 1984;11:39-43
42. Bocchetta A, Bernardi F, Burrai C, et al. The course of thyroid abnormalities during lithium treatment: a two-year follow-up study. Acta Psychiatr Scand 1992;86:38-41
43. Lombardi G, Panza N, Biondi B, et al. Effects of lithium treatment on hypothalamic-pituitary-thyroid axis: a longitudinal study. J Endocrinol Invest 1993;16:259-263
44. 4) and serum thyroid stimulating hormone (TSH) during prolonged lithium treatment. Acta Psychiatr Scand 1987;75:2217-2221
45. Lazarus JH, John R, Bennie EH, et al. Lithium therapy and thyroid function: a long-term study. Psychol Med 1981;11:85-92
46. Calabrese JR, Gulledge DA, Hahn K, et al. Autoimmune thyroiditis in manic-depressive patients treated with lithium. Am J Psychiatry 1985;142: 1318-1321
47. Schou M, Amidsen A, Eskjaer J, et al. Occurrence of goiter during lithium treatment. BMJ 1968;3:710-713
48. McLarty DG, O'Boyle JH, Spencer CA, et al. Effect of lithium on hypothalamic-pituitary-thyroid function in patients with affective disorders. BMJ 1975;3:623-626
49. Myers DH, Carter BHB, Armond A, et al. A prospective study of the effect of lithium on thyroid function and on the prevalence of antithyroid antibodies. Psychol Med 1985;15:55-61
50. Transbol I, Christiansen C, Baastrup PC. Endocrine effects of lithium, I: hypothyroidism, its prevalence in long-term treated patients. Acta Endocrinol (Copenh) 1978;87:759-767
51. Leroy MC, Villeneuve A, Lajeunesse C. Lithium, thyroid function and antithyroid antibodies. Prog Neuropsychopharmacol Biol Psychiatry 1988;12:483-490
52. Lervang HH, Pryds O, Ostergaard Kristensen HP. Thyroid dysfunction after delivery: incidence and clinical course. Acta Med Scand 1987;222: 369-374
53. Schubert MF, Kountz DS. Thyroiditis: a disease with many faces. Postgrad Med 1995;98:101-112
54. Brody MB, Reichard RA. Thyroid screening: how to interpret and apply the results. Postgrad Med 1995;98:54-65
55. Gordin A, Lamberg BA. Natural course of symptomless autoimmune thyroiditis. Lancet 1975;2:1234-1237
56. Gordin A, Lamberg BA. Spontaneous hypothyroidism in symptomless autoimmune thyroiditis: a long-term follow-up study. Clin Endocrinol (Oxf) 1981;15:537-543
57. Lazarus JH, McGregor AM, Ludgale M. Effect of lithium carbonate therapy on thyroid immune status in manic depressive patients: a prospective study. J Affect Disord 1986;11:155-160
58. Emerson CH, Dyson WL, Utige RD. Serum thyrotropin and thyroxine concentrations in patients receiving lithium carbonate. J Endocrinol Metab 1973;36:338-346
59. Salata R, Klein I. Effects of lithium on the endocrine system: a review. J Lab Clin Med 1987;110:130-136
60. Yassa R, Saunders A, Nastase C, et al. Lithium-induced thyroid disorders: a prevalence study. J Clin Psychiatry 1988;49:14-16
61. Stancer HC, Forbath N. Hyperparathyroidism, hypothyroidism, and impaired renal function after 10 to 20 years of lithium treatment. Arch Intern Med 1989;149:1042-1045
62. Rappaport MR, Schmidt ME, Risinger R, et al. Effects of prolonged lithium exposure on the immune system of normal control subjects: serial serum soluble interleukin-2 receptor and antithyroid antibody measurements. Biol Psychiatry 1994;35:761-766
63. Urabe M, Hershman J, Pang X, et al. Effect of lithium on function and growth of thyroid cells in vitro. Endocrinology 1991;129:807-814
64. Bagchi N, Brown TR, Mack RE. Studies on the mechanism of inhibition of thyroid function by lithium. Biochim Biophys Acta 1978;542: 163-169
65. Spaulding W, Burrow GN, Bermudez F, et al. The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients. J Clin Endocrinol Metab 1972;35:905-911
66. Mon M, Tajima K, Oda Y, et al. Inhibitory effect of lithium on the release of thyroid hormones from thyrotropin-stimulated mouse thyroids in a perifusion system. Endocrinology 1989;124:1365-1369
67. Havas ST, Hershman JM. Lithium and Thyroid Function: Thyroid and Trace Elements [videotape], Braverman LE, Kohrle J, Eber O, et al, eds. Vienna, Austria: Blackwell; 1996
68. Whybrow PC. Sex differences in thyroid axis function: relevance to affective disorder and its treatment. Depression 1995;3:33-42
69. Bhattacharyya B, Wolff J. Stabilization of microtubules by lithium ion. Biochem Biophys Res Commun 1976;73:383-390
70. Deniker P, Eyquem A, Bernheim R, et al. Thyroid autoantibody levels during lithium therapy. Neuropsychobiology 1978;4:270-275
71. Wilson R, McKillop JH, Crocket GT, et al. The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin Endocrinol (Oxf) 1991;34:357-361
72. Weetman AP, McGregor AM, Lazarus JH, et al. The enhancement of immunoglobulin synthesis by human lymphocytes with lithium. Clin Immunol Immunopathol 1982;22:400-407
73. Haggerty JJ Jr, Evans DL, Golden RN, et al. The presence of antithyroid antibodies in patients with affective and nonaffective psychiatric disorders. Biol Psychiatry 1990;27:51-60
74. Billewicz WZ, Chapman RS, Crooks J, et al. Statistical methods applied to the diagnosis of hypothyroidism. Q 4 Med 1969;150:255-266
75. Osterweil D, Syndulko K, Cohen SN, et al. Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc 1992;40: 325-335
76. Nemeroff CB. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. J Clin Psychiatry 1989;50 (5, suppl):13-20
77. Bartalena L, Pellegrini L, Meschi M, et al. Evaluation of thyroid function in patients with rapid-cycling and non-rapid cycling bipolar disorder. Psychiatry Res 1990;34:13-17
78. Leibenluft E. Women with bipolar illness: clinical and research issues. Am J Psychiatry 1996;153:163-173
79. Bernstein L. Abrupt cessation of rapid-cycling bipolar disorder with the addition of low-dose L-tetraiodothyronine to lithium. J Clin Psychopharmacol 1992;12:443-444
80. Leibow D. L-Thyroxine for rapid-cycling bipolar illness. Am J Psychiatry 1983;140:1255
81. Stancer H, Persad E. Treatment of intractable rapid-cycling manic depressive disorder with levothyroxine: clinical observations. Arch Gen Psychiatry 1982;39:311-312
82. Wehr T, Sack D, Rosenthal N, et al. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988;145:179-184
83. Crantz FR, Silva JE, Larsen PR. Analysis of the sources and quantity of 3,5,3′-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology 1982;110:367-375
84. Dratman M, Crutchfield F. Iodothyronine homeostasis in rat brain during hypo- and hyperthyroidism. Am J Physiol 1983;245:E185-E193
85. Madeira NS, Lima-Andrade MT, Calheiros F, et al. Selective vulnerability of the hippocampal pyramidal neurons to hypothyroidism in male and female rats. J Comp Neurol 1992;322:501-518
86. Maxmen JS, Ward NG. Psychotropic Drugs: Fast Facts. New York, NY: WW Norton; 1995:200-211, 392
87. Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995;273:808-812
88. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995;152: 1130-1138
89. Kukopulos A, Reginaldi D, Laddomada P, et al. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol 1980;13:156-167
90. Pies R. Psychiatric disorders and the thyroid. Psychiatric Times. November 1995:15-16
91. Whybrow P, Prange A. Receptor interaction. Arch Gen Psychiatry 1981; 30:107-113
92. Coindre J, David J, Riviere L, et al. Bone loss in hypothyroidism with hormone replacement: a histomorphometric study. Arch Intern Med 1986; 146:48-53
93. Stall GM, Harris S, Sokoll LJ, et al. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med 1990;113:265-269
94. Franklyn JA, Sheppard MC. Thyroxine replacement treatment and osteoporosis. BMJ 1990;300:603-604
95. Ross DS. Subclinical hyperthyroidism: possible danger of overzealous thyroxine replacement therapy. Mayo Clin Proc 1988;63:1223-1229
96. Muller CG, Bayley A, Harrison JE, et al. Possible limited bone loss with suppressive thyroxine therapy is unlikely to have clinical relevance. Thyroid 1995;5:81-87